INTRODUCTION {#sec1-1}
============

One of the most important heart diseases is mitral stenosis (MS) that can due to left atrial and left atrial appendage clot. In 90% of atrial fibrillation, blood clots forms in the left atrial appendage (LAA) and they may lead to emboli, which can lead to ischemic damage to the brain, kidneys or other organs supplied by the systemic circulation.\[[@ref1]\] Left atrial appendage occlusion is a treatment strategy to prevent blood clot formation in left atrium.\[[@ref2]\]

The efficacy of oral anticoagulation (OAC) for stroke prevention in patients with non-rheumatic atrial fibrillation (AF) has clearly been established. However, mitral valve diseases with severe stenosis usually do not response to medical treatment.\[[@ref3]\]

Percutaneous trans catheter trans septal approach to LAA was done for excluding it from the systemic circulation.\[[@ref4]\] Also, Healy *et al*. showed LAA occlusion during coronary artery bypass grafting (CABG) was safe and could use to prevent stroke.\[[@ref5]\] LAA occlusion can be used as an alternative for patients who cannot use oral anticoagulants because of a recent or previous bleeding, pregnancy and so on.\[[@ref3]\] This goes especially for the elderly, although studies have indicated that they can also benefit from anticoagulants.\[[@ref6]\] Although LAA occlusion, usually was done by catheter-based techniques,\[[@ref7]\] it can be done during closed mitral valve commissurotomy (CMVC), open mitral valve commissurotomy (OMVC) and mitral valve replacement (MVR) too.\[[@ref5][@ref8]\] Nowadays, PTMC is performed as an optimal management of severe mitral stenosis (MS) and many patients currently are treated by PTMC instead of previous surgical methods. One of the most important contraindications of PTMC is presence of clot in LAA. So each patient who suffers of severe MS is evaluated by TEE to rule out thrombus in LAA before PTMC.

Because the left atrial appendix (LAA) is the most common place of thrombosis formation in patients with atrial fibrillation (AF) and mitral stenosis (MS), it can easily be excluded from the systemic circulation at the time of cardiac surgery by excision, ligation, suturing, or stapling. The ongoing LAA occlusion study (LAAOS) is evaluating the efficacy of the routine LAA occlusion in patients undergoing elective coronary artery bypass graft surgery. Recently, two devices specifically designed for percutaneous trans-catheter LAA occlusion have been introduced: the percutaneous LAA trans-catheter occlusion (PLAATO; Appriva Medical Inc) and WATCHMAN LAA system (Atritech, Inc).\[[@ref9]\]

Trans-esophageal echocardiography (TEE) is one of the best tools for recognize thrombus in LAA and it is currently used for any patients who are suspected of LAA clot.\[[@ref10]\] Around surgery, a TEE has to be performed to judge completeness of closure and the presence of blood clots.

CASE REPORT {#sec1-2}
===========

A 49-year-old woman was admitted to the Sina Heart Institute in Isfahan in Iran for mitral valve replacement on 18 July 2011. She had become progressively symptomatic since September of 2008. An irregular heartbeat had been present for many years. During the past several years, her physical activities were reduced significantly and she had recently become more symptomatic. Medical therapy of the patient included digoxin, diuretic and warfarin.

On admission the patient had an irregular pulse with an apical rate of 80-100 beat/min. The first heart sound was increased; a loud opening snap and a long, grade 3/6, diastolic, rumbling murmur, in addition to grade 3/6 pan systolic murmur were best heard at the apex in the fifth intercostal space in mid-clavicular line. Electrocardiography showed atrial fibrillation with a ventricular rate of approximately 80-100 beat/min and nonspecific ST-T changes. Last echocardiography showed severe mitral stenosis (MS) and regurgitation. Angiography of coronary arteries was normal.

Intra operative TEE was done just few min before surgery. Ejection fraction was 40%. There were mitral stenosis and mitral regurgitation 3/4+. Echocardiography revealed left atrial and ventricular enlargement; the mitral valve configuration was consistent with calcific mitral stenosis. Investigation of LA and LAA did not show clot \[[Figure 1](#F1){ref-type="fig"}\].

![Pre-surgery echo of left atrial appendage](IJPVM-4-102-g001){#F1}

At open heart surgery, replacement of the mitral valve was performed and it replaced with artificial valve. Left atrial appendage occlusion was done during surgery. Post-pump TEE demonstrated an echo imitated the presence of a clot in left atrial appendage area \[[Figure 2](#F2){ref-type="fig"}\]. Indeed thrombus was filled the LAA and this thrombus would be organized with no chance of emboli. The post-operative course was uneventful, and the patient was discharged on 27 July 2011.

![Post-surgery echo of left atrial appendage](IJPVM-4-102-g002){#F2}

DISCUSSION {#sec1-3}
==========

Left atrial thrombi are a relatively frequent finding in patients with mitral stenosis and left atrial thrombi are usually located in the left atrial appendage. Left atrial appendage occlusion may cause a thick, non-mobile echo finding that mimics the presence of a thrombus and discrimination of these two entities is difficult by surgery so we should obtain exact history of previous surgeries, especially left atrial appendage occlusion, when we suspect to thrombus of left atrial. It can prevent additional evaluations and treatments such as oral anticoagulation and exclusion or postponing surgeries including PTMC.
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